Purity is published only against a lot-matched COA.
£44.99
Qty
1
Total
£44.99
In stock · ships today
Research use only · Not for human or veterinary use
Guaranteed safe checkoutVISAMASTERCARDAMEX
Third-party HPLC tested
Certificate for every lot
Tracked, discreet shipping
Secure checkout
Research use only • Not for human or veterinary use
Peptide research material · Capsule format
Grindlab Tirzepatide
Supplied as a single-compound capsule preparation labelled at 10 mg per capsule, thirty capsules to the bottle. The submitted sample carries an independent Janoshik laboratory report, shown in full below with the reported amount recorded for the tested capsule.
The supplied laboratory information covers a single Tirzepatide capsule sample labelled at 10 mg. The label value and the laboratory-reported amount are kept distinct throughout, and the bottle quantity is stated as supplied.
Labelled strength10 mg
Laboratory-reported amount of 10.21 mg per tested capsule, recorded under task #65265.
Bottle quantity30 capsules
Supplied in one clearly labelled Grindlab bottle as a single-compound preparation.
Material formatCapsules
Supplied under the Grindlab Tirzepatide naming and identified as Tirzepatide in the submitted record.
Product documentation
Label value and reported result kept separate
The product label, laboratory task number, identified material and reported capsule amount are displayed exactly as recorded — without adding purity, batch-wide consistency or quality-control claims.
01
One labelled sample
The submitted laboratory sample is named Tirzepatide and labelled at 10 mg per capsule.
02
Reported identity
The supplied Janoshik record identifies the submitted sample as Tirzepatide.
03
Quantitative result
The record states 10.21 mg per tested capsule against the 10 mg label value.
Documentation overview
How the result maps to the sample
The supplied laboratory result is connected to its corresponding submitted sample, task number and capsule count so the recorded details can be reviewed together.
01
Sample named
The record lists the submitted sample as Tirzepatide, labelled 10 mg per capsule.02
Task recorded
Task #65265 corresponds to the submitted Grindlab Tirzepatide capsule sample.03
Amount reported
The record includes a laboratory-reported amount of 10.21 mg for the tested capsule.04
Scope stated
The result relates to the submitted sample and does not imply testing of every capsule in the bottle.
Laboratory documentation
Grindlab Tirzepatide 10 mg report
Supplied Janoshik laboratory documentation for the submitted Tirzepatide capsule sample, presented beside the recorded task details.
Each bottle contains Grindlab Tirzepatide capsules labelled at 10 mg per capsule, supplied as a single-compound preparation.
How many capsules are included?
Each bottle contains 30 capsules.
Is a laboratory report available?
Yes. An independent Janoshik laboratory report, recorded under task #65265, is displayed directly on this product page.
Are the label value and reported amount the same thing?
No. The 10 mg figure is the supplied capsule label value. The separate laboratory-reported amount is 10.21 mg for the tested capsule.
What amount was reported in the tested sample?
The displayed laboratory report records 10.21 mg in the tested capsule sample.
Does the result apply to every capsule?
The result relates to the submitted laboratory sample. The supplied information does not establish that every capsule in the bottle was individually tested.
What is the intended use?
This material is supplied strictly for laboratory research purposes and is not intended for human or veterinary use.
Research use only
Grindlab Tirzepatide is supplied solely as a laboratory research material. It is not intended for human or veterinary consumption, administration, diagnosis, treatment, or performance enhancement. No representation is made regarding purity, batch-wide consistency, safety or effectiveness in humans.
